{{Chembox
| ImageFile = Pafenolol.svg
| ImageSize = 200px
| ImageAlt = 
| IUPACName = 1-[2-[4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl]ethyl]-3-propan-2-ylurea
| OtherNames = 
|Section1={{Chembox Identifiers
| CASNo = 80015-07-2
| PubChem = 71144
| ChemSpiderID = 64289
| SMILES = CC(C)NCC(COC1=CC=C(C=C1)CCNC(=O)NC(C)C)O
| InChI = 1/C18H31N3O3/c1-13(2)20-11-16(22)12-24-17-7-5-15(6-8-17)9-10-19-18(23)21-14(3)4/h5-8,13-14,16,20,22H,9-12H2,1-4H3,(H2,19,21,23)
| InChIKey = PKWZWSXSCKVUJB-UHFFFAOYAJ
| StdInChI = 1S/C18H31N3O3/c1-13(2)20-11-16(22)12-24-17-7-5-15(6-8-17)9-10-19-18(23)21-14(3)4/h5-8,13-14,16,20,22H,9-12H2,1-4H3,(H2,19,21,23)
<!--| InChIKey = PKWZWSXSCKVUJB-UHFFFAOYSA-N-->
 }}
|Section2={{Chembox Properties
| C=18 | H=31 | N=3 | O=3 
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = 
 }}
}}

'''Pafenolol''' is a [[beta adrenergic receptor antagonist]].<ref>{{cite journal|pmid=8100631|year=1993|last1=Lennernäs|first1=H|last2=Regårdh|first2=CG|title=Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat|volume=10|issue=5|pages=727–31|journal=Pharmaceutical Research|doi=10.1023/a:1018916017723 }}</ref>

==References==
{{Reflist}}


{{Adrenergics}}

[[Category:Beta blockers]]
[[Category:Ureas]]


{{organic-compound-stub}}
{{pharma-stub}}